Variants of the ADRB2 Gene in COPD: Systematic Review and Meta-Analyses of Disease Risk and Treatment Response.

doi:10.1080/15412555.2017.1320370

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Variants of the ADRB2 Gene in COPD: Systematic Review and Meta-Analyses of Disease Risk and Treatment Response.

COPD - 1 Aug 2017

Nielsen Anne Orholm, Jensen Camilla Steen, Arredouani Mohamed Simo, Dahl Ronald, Dahl Morten

Abstract excerpt

The β2-adrenergic receptor (ADRB2) is an important regulator of airway smooth muscle tone in chronic obstructive pulmonary disease (COPD). Variants that impair ADRB2 function could increase disease risk or reduce the response to endogenous and inhaled adrenergic agonists in COPD. We performed a systematic review and three meta-analyses to assess whether three functional variants (Thr164Ile, Arg16Gly, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Inhalation
Share to Adrenergic beta-2 Receptor Agonists
Share to Black People
Share to Bronchodilator Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pulmonary Disease, Chronic Obstructive

Share to Receptors, Adrenergic, beta-2

Share to Treatment Outcome

Share to White People

Source

Open in PubMed

Identifiers

PMID: 28506092
DOI: 10.1080/15412555.2017.1320370

Genes

ADRB2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.